Stage 2. RCT of conventional RARP vs molecularly-targeted intraoperative fluorescence. Trials unit @SITU_Oxford. Funder @CR_UK. CI @lambalastair. @NDSurgicalSci

Oxford, England
Joined June 2022
Really great to see this exciting new data from @hvdpoel et al from @NKI_nl in @TheLancetOncol. Beautiful, meticulous science. Paving the way for a future of molecular fluorescence-guided prostate surgery. Bring on the #RCTs, #PROMOTE_Study recruiting! thelancet.com/journals/lanon…
3
13
796
After a hiatus, #PROMOTE_Study recruiting apace with 12 men now in stage 2 of trial (RCT). 3rd RARP in 'fluorescence arm' performed today. Visualising areas of cancer nicely. And all neatly recorded using @Proximie! @NDSurgicalSci @SITU_Oxford
1
7
1
19
2,264
Pleased to share our first manuscript from #PROMOTE_Study Detailed genomic analysis of n=5 men from the trial w multifocal heterogeneous primary #ProstateCancer each with #LNmets •Adeno, amphicrine & NE #PCa •Clonal evolution •Routes of progression biorxiv.org/content/10.1101/…
12
21
2,500
Pleased to report that we've performed first two #FluorescenceGuided #RARPs of #ProMOTE_Study Stage 2. Some great innovations to enhance fluoro tissue imaging compared w Stage 1. Great team-work to get re-opened n=120 1:1 RARP vs fluoro RARP 1°=complete excision #Oxford_Urology
1
2
14